T0	Disease 34 43	cirrhotic
T11	Chemical 548 550	NO
T12	Chemical 637 640	eNO
T14	Chemical 682 685	eNO
T15	Disease 718 741	decompensated cirrhosis
#5	AnnotatorNotes T15	not found
T16	Disease 751 785	intrapulmonary vascular dilatation
#6	AnnotatorNotes T16	not found
T18	Disease 803 836	hyperdynamic circulatory syndrome
#7	AnnotatorNotes T18	not found
T2	Chemical 99 101	NO
T20	Disease 841 865	hepatopulmonary syndrome
#9	AnnotatorNotes T20	DOID:900
T23	Chemical 894 897	eNO
T24	Chemical 1089 1092	eNO
T25	Chemical 1246 1249	eNO
T26	Disease 1427 1436	cirrhosis
#13	AnnotatorNotes T26	DOID:5082
T27	Chemical 1517 1520	eNO
T28	Disease 1548 1563	liver cirrhosis
#15	AnnotatorNotes T28	DOID:5082
T29	Chemical 1601 1604	eNO
T3	Chemical 317 319	NO
T4	Chemical 369 376	nitrate
T5	Chemical 381 388	nitrite
T6	Chemical 435 437	NO
T7	Chemical 461 471	L-arginine
T8	Chemical 476 482	oxygen
T9	Disease 514 523	cirrhotic
T1	Biomarker 58 85	increased expression of NOS
T10	Biomarker 90 135	elevated NO concentration in peripheral blood
T13	Biomarker 158 220	decrease in the inactivating effect of the liver on endotoxins
T17	Biomarker 225 287	increased concentration of endotoxins in the blood circulation
T19	Collection 718 865	decompensated cirrhosis, such as intrapulmonary vascular dilatation complicated with hyperdynamic circulatory syndrome and hepatopulmonary syndrome
T21	Biomarker 670 685	increase in eNO
R1	Association Arg1:T21 Arg2:T19	
T22	Biomarker 871 897	excessive elevation of eNO
T33	Biomarker 934 1059	increase in the release from pulmonary vascular endothelial cells, airway epithelial cells, and peripheral inflammatory cells
#1	AnnotatorNotes T0	DOID:5082
T30	Disease 1655 1684	cirrhotic portal hypertension
#2	AnnotatorNotes T30	DOID:5082,DOID:10762
T31	Disease 1686 1689	CPH
#3	AnnotatorNotes T31	DOID:5082,DOID:10762
T32	Biomarker 1601 1604	eNO
T34	Biomarker 1517 1520	eNO
T35	GeneFamily 82 85	NOS
#4	AnnotatorNotes T35	not found
T36	GeneFamily 506 509	NOS
T42	Biomarker 621 654	increase in the eNO concentration
T37	Biomarker 538 605	increased NO levels in pulmonary small airways and alveolar regions
